title: Advancing Immune and Cell-Based Therapies Through Imaging.
abstract: Immunotherapies include various approaches, ranging from stimulating effector mechanisms to counteracting inhibitory and suppressive mechanisms, and creating a forum for discussing the most effective means of advancing these therapies through imaging is the focus of the newly formed Imaging in Cellular and Immune Therapies (ICIT) interest group within the World Molecular Imaging Society. Efforts are being made in the identification and validation of predictive biomarkers for a number of immunotherapies. Without predictive biomarkers, a considerable number of patients may receive treatments that have no chance of offering a benefit. This will reflect poorly on the field of immunotherapy and will yield false hopes in patients while at the same time contributing to significant cost to the healthcare system. This review summarizes the main strategies in cancer immune and cell-based therapies and discusses recent advances in imaging strategies aimed to improve cancer immunotherapy outcomes.
authors.affiliation: Department of Radiology, Molecular Pharmacology and Chemistry Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, 1275 York Ave Z-2063, Box 501, New York, NY, 10065, USA. ponomarv@mskcc.org.
authors.forename: Vladimir
authors.identifier: 0000-0002-9119-9128
authors.initials: V
authors.lastname: Ponomarev
mesh_terms: D000818:Animals; D015415:Biomarkers / Q000032:analysis; D006801:Humans; D007167:Immunotherapy / Q000379:methods* / Q000639:trends*; D007962:Leukocytes / Q000166:cytology; D057054:Molecular Imaging / Q000379:methods*; D017063:Outcome Assessment, Health Care
chemical_list: D015415:Biomarkers
keywords: Cell-based therapy; Imaging; Immunotherapy